Targeting cytokine storm in COVID-19: what have we learned?
作者信息
Ridker Paul M
机构信息
Department of Medicine, Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, MA 02215, USA.
出版信息
Eur Heart J Open. 2021 Jul 29;1(1):oeab005. doi: 10.1093/ehjopen/oeab005. eCollection 2021 Aug.
Abstract
摘要
相似文献
1
Targeting cytokine storm in COVID-19: what have we learned?针对新冠病毒肺炎中的细胞因子风暴：我们学到了什么？
Eur Heart J Open. 2021 Jul 29;1(1):oeab005. doi: 10.1093/ehjopen/oeab005. eCollection 2021 Aug.
2
Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.新型冠状病毒肺炎（COVID-19）中的细胞因子风暴：专家管理考量
Indian J Crit Care Med. 2020 Jun;24(6):429-434. doi: 10.5005/jp-journals-10071-23415.
3
Triangle of cytokine storm, central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1.细胞因子风暴、中枢神经系统受累和 COVID-19 病毒感染的三角关系：sFasL 和神经纤毛蛋白-1 的作用。
Rev Neurosci. 2021 Jul 6;33(2):147-160. doi: 10.1515/revneuro-2021-0047. Print 2022 Feb 23.
4
Can help control cytokine storm in COVID-19?能否有助于控制新冠病毒疾病中的细胞因子风暴？
J Ginseng Res. 2022 May;46(3):337-347. doi: 10.1016/j.jgr.2022.02.006. Epub 2022 Feb 25.
5
Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.住院的COVID-19患者中不存在“细胞因子风暴”：一项回顾性队列研究。
Infect Dis Rep. 2021 Apr 19;13(2):377-387. doi: 10.3390/idr13020036.
6
Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.凝血功能障碍作为新冠病毒感染患者细胞因子风暴的前驱症状
Front Med (Lausanne). 2020 Oct 23;7:572989. doi: 10.3389/fmed.2020.572989. eCollection 2020.
7
Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.利用与疾病相关的血液生物标志物区分 COVID-19 与炎症诱导的细胞因子风暴综合征。
Arthritis Rheumatol. 2021 Oct;73(10):1791-1799. doi: 10.1002/art.41763. Epub 2021 Sep 3.
8
Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm.靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）诱导的细胞因子风暴管理中的特定检查点
Life (Basel). 2022 Mar 25;12(4):478. doi: 10.3390/life12040478.
9
Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.COVID-19 和 CAR-T 治疗中的大脑功能障碍：细胞因子风暴相关脑病。
Ann Clin Transl Neurol. 2021 Apr;8(4):968-979. doi: 10.1002/acn3.51348. Epub 2021 Mar 29.
10
Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.针对重症 COVID-19 中炎症调节微小 RNA 的营养保健品靶向治疗：预防细胞因子风暴的新方法
Front Pharmacol. 2020 Dec 11;11:602999. doi: 10.3389/fphar.2020.602999. eCollection 2020.
引用本文的文献
1
COVID-19 Related Myocarditis in Adults: A Systematic Review of Case Reports.成人 COVID-19 相关心肌炎：病例报告的系统评价
J Clin Med. 2022 Sep 21;11(19):5519. doi: 10.3390/jcm11195519.
2
Open Up your Science in .以……方式开启你的科学探索
Eur Heart J Open. 2021 Aug 27;1(1):oeab021. doi: 10.1093/ehjopen/oeab021. eCollection 2021 Aug.
本文引用的文献
1
Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation.卡那单抗治疗新型冠状病毒肺炎相关心脏损伤及炎症加剧患者的双盲随机概念验证试验
Eur Heart J Open. 2021 Jul 29;1(1):oeab002. doi: 10.1093/ehjopen/oeab002. eCollection 2021 Aug.
2
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.秋水仙碱治疗社区治疗的 COVID-19 患者（COLCORONA）：一项 3 期、随机、双盲、适应性、安慰剂对照、多中心试验。
Lancet Respir Med. 2021 Aug;9(8):924-932. doi: 10.1016/S2213-2600(21)00222-8. Epub 2021 May 27.
3
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.托珠单抗治疗 COVID-19 住院患者的疗效（RECOVERY）：一项随机、对照、开放标签、平台试验。
Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0.
4
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.托珠单抗治疗重症 COVID-19 肺炎住院患者。
N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.
5
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.COVID-19 重症患者的白细胞介素 6 受体拮抗剂。
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
6
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.托珠单抗治疗新冠肺炎合并肺炎住院患者的疗效。
N Engl J Med. 2021 Jan 7;384(1):20-30. doi: 10.1056/NEJMoa2030340. Epub 2020 Dec 17.
7
Cytokine Storm.细胞因子风暴
N Engl J Med. 2020 Dec 3;383(23):2255-2273. doi: 10.1056/NEJMra2026131.
8
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.托珠单抗治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21.
9
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
10
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
Zotero 插件